Literature DB >> 16737949

Trends in breast cancer by race and ethnicity: update 2006.

Carol Smigal1, Ahmedin Jemal, Elizabeth Ward, Vilma Cokkinides, Robert Smith, Holly L Howe, Michael Thun.   

Abstract

In this article, the American Cancer Society (ACS) provides estimates of new breast cancer cases and deaths in 2006 and describes trends in incidence, mortality, and survival for female breast cancer in the United States. These estimates are based on incidence data from the National Cancer Institute (NCI) and the North American Association of Central Cancer Registries, which includes state data from NCI and the National Program of Cancer Registries of the Centers for Disease Control and Prevention and mortality data from the National Center for Health Statistics for the most recent years available (1975 to 2002). This article also shows trends in screening mammography. Approximately 212,920 new cases of invasive breast cancer, 61,980 in situ cases, and 40,970 deaths are expected to occur among US women in 2006. As previously reported, breast cancer incidence rates increased rapidly among women of all races from 1980 to 1987, a period when there was increasing uptake of mammography by a growing proportion of US women, and then continued to increase, but at a much slower rate, from 1987 to 2002. Trends in incidence vary by age, race, socioeconomic status, and stage. The continuing increase in incidence (all stages combined) is limited to White women age 50 and older; recent trends are stable for African American women age 50 and older and White women under age 50 years and are decreasing for African American women under age 50 years. Although incidence rates (all races combined) are substantially higher for women age 50 and older (375.0 per 100,000 females) compared with women younger than 50 years (42.5 per 100,000 females), approximately 23% of breast cancers are diagnosed in women younger than 50 years because those women represent 73% of the female population. For women age 35 and younger, age-specific incidence rates are slightly higher among African Americans compared with Whites but then cross over so that Whites have substantially higher incidence at all later ages. Among women of all races and ages, breast cancer mortality rates declined at an average rate of 2.3% per year between 1990 and 2002, a trend that reflects progress in both early detection and treatment. However, death rates in African American women remain 37% higher than in Whites, despite lower incidence rates. Although, in national surveys, approximately 70% of women age 40 years and older report having had a mammogram in the past 2 years, rates vary by race/ethnicity and are markedly lower among women with lower levels of education, without health insurance, and in recent immigrants. Furthermore, a recent study suggests that the true percentage of women having regular mammography is lower than reported in survey data. Encouraging patients age 40 years and older to have annual mammography and clinical breast exam is the single most important step that clinicians can take to reduce suffering and death from breast cancer. Clinicians should also ensure that patients at high risk of breast cancer are identified and offered appropriate referrals and treatment. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population.

Entities:  

Mesh:

Year:  2006        PMID: 16737949     DOI: 10.3322/canjclin.56.3.168

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  231 in total

1.  Breast cancer knowledge and early detection among Hispanic women with a family history of breast cancer along the U.S.-Mexico border.

Authors:  Yelena Bird; John Moraros; Matthew P Banegas; Sasha King; Surasri Prapasiri; Beti Thompson
Journal:  J Health Care Poor Underserved       Date:  2010-05

2.  Pharmacogenomic diversity of tamoxifen metabolites and estrogen receptor genes in Hispanics and non-Hispanic whites with breast cancer.

Authors:  Leticia B A Rangel; Jodi L Taraba; Christopher R Frei; Lon Smith; Gladys Rodriguez; John G Kuhn
Journal:  Breast Cancer Res Treat       Date:  2014-11-14       Impact factor: 4.872

3.  The Symptom Cluster of Sleep, Fatigue and Depressive Symptoms in Breast Cancer Patients: Severity of the Problem and Treatment Options.

Authors:  Lavinia Fiorentino; Michelle Rissling; Lianqi Liu; Sonia Ancoli-Israel
Journal:  Drug Discov Today Dis Models       Date:  2011

4.  Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Authors:  C-R Pradeep; A Zeisel; W J Köstler; M Lauriola; J Jacob-Hirsch; B Haibe-Kains; N Amariglio; N Ben-Chetrit; A Emde; I Solomonov; G Neufeld; M Piccart; I Sagi; C Sotiriou; G Rechavi; E Domany; C Desmedt; Y Yarden
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

Review 5.  Pharmacogenetics of drug metabolizing enzymes and transporters: effects on pharmacokinetics and pharmacodynamics of anticancer agents.

Authors:  Norman H Lee
Journal:  Anticancer Agents Med Chem       Date:  2010-10-01       Impact factor: 2.505

6.  Transplantation of β-endorphin neurons into the hypothalamus promotes immune function and restricts the growth and metastasis of mammary carcinoma.

Authors:  Dipak K Sarkar; Changqing Zhang; Sengottuvelan Murugan; Madhavi Dokur; Nadka I Boyadjieva; Maria Ortigüela; Kenneth R Reuhl; Sepide Mojtehedzadeh
Journal:  Cancer Res       Date:  2011-08-11       Impact factor: 12.701

7.  Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?

Authors:  Erica T Warner; Rulla M Tamimi; Deborah A Boggs; Bernard Rosner; Lynn Rosenberg; Graham A Colditz; Julie R Palmer
Journal:  Cancer Causes Control       Date:  2013-02-05       Impact factor: 2.506

8.  Epidemiology of basal-like breast cancer.

Authors:  Robert C Millikan; Beth Newman; Chiu-Kit Tse; Patricia G Moorman; Kathleen Conway; Lynn G Dressler; Lisa V Smith; Miriam H Labbok; Joseph Geradts; Jeannette T Bensen; Susan Jackson; Sarah Nyante; Chad Livasy; Lisa Carey; H Shelton Earp; Charles M Perou
Journal:  Breast Cancer Res Treat       Date:  2007-06-20       Impact factor: 4.872

9.  The timeliness of patients reporting the side effects of chemotherapy.

Authors:  Ian Olver; Mariko Carey; Allison Boyes; Alix Hall; Natasha Noble; Jamie Bryant; Justin Walsh; Rob Sanson-Fisher
Journal:  Support Care Cancer       Date:  2018-05-03       Impact factor: 3.603

10.  Bone health issues in breast cancer survivors: a Medicare Current Beneficiary Survey (MCBS) study.

Authors:  Luke J Peppone; Karen M Mustian; Randy N Rosier; Jennifer K Carroll; Jason Q Purnell; Michelle C Janelsins; Gary R Morrow; Supriya G Mohile
Journal:  Support Care Cancer       Date:  2013-09-17       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.